Study to Test Genetic Alterations Among Different Dermoscopic Types of Melanocytic Nevi.
Primary Purpose
Nevi
Status
Completed
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
To test the frequency of BRAF and NRAS mutations among nevi
Sponsored by
About this trial
This is an interventional basic science trial for Nevi focused on measuring Dermoscopy, Histopathology, Genetics, Nevi, Nevogenesis
Eligibility Criteria
Inclusion Criteria:
- Healthy individuals aged 9 to 80 years showing one or more dermoscopically benign nevi with either uniform globular-cobblestone pattern or reticular pattern or a combination of both types
Exclusion Criteria:
- Children under the age of 9 years
- Pregnant woman
- Patients with atypical nevi (i.e., melanoma cannot be clinically ruled out)
- Patients with immunosuppression
- Patients with sun exposure 4 weeks before enrollment
Sites / Locations
- Department of Dermatology, Medical University of Graz
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Nevi from participants
Arm Description
Benign nevi dermoscopically sub-classified into 4 dermoscopic types (i.e., with globular, reticular, mixed pattern with globules in the center and mixed pattern with globules at the periphery) were excised from healthy volunteers for further genetical analysis
Outcomes
Primary Outcome Measures
Frequency of BRAF Mutations Among Nevi
All nevi were analyzed for BRAF mutations using the (less sensitive) Sanger method. A random subset of nevi was also analyzed using the (more sensitive) Ultradeep pyro-sequencing method (UDPS). The frequency is reported here as the number of BRAF mutations found by each method.
Secondary Outcome Measures
Frequency of NRAS Mutations Among Nevi
All nevi were analyzed for NRAS mutations using the (less sensitive) Sanger method. The (more sensitive) Ultradeep pyro-sequencing method (UDPS) is not applicable for this mutation. The frequency is reported here as the number of NRAS mutations from the analyzed nevi.
Full Information
NCT ID
NCT00422448
First Posted
January 15, 2007
Last Updated
December 14, 2010
Sponsor
Medical University of Graz
1. Study Identification
Unique Protocol Identification Number
NCT00422448
Brief Title
Study to Test Genetic Alterations Among Different Dermoscopic Types of Melanocytic Nevi.
Official Title
BRAF and Nevi.Nevi Are Common Benign Pigmented Tumors of the Skin. Mutations in So-called BRAF and NRAS Genes Genes Appear to be Initiating Events Responsible for the Formation of Nevi.
Study Type
Interventional
2. Study Status
Record Verification Date
December 2010
Overall Recruitment Status
Completed
Study Start Date
September 2006 (undefined)
Primary Completion Date
March 2009 (Actual)
Study Completion Date
April 2010 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Medical University of Graz
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This project is a multicenter study in which we will investigate a dual concept of nevogenesis. Study location is the Department of Dermatology at the Medical University of Graz in collaboration with centers in Austria (Vienna), Italy (Naples, Benevento, Modena), Spain (Barcelona) and the United States (New York).
The hypothesis is that small congenital melanocytic nevi (CMN), "early" acquired melanocytic nevi in childhood (AMN) and dermal nevi, all dermatoscopically characterized by globular pattern, belong to the same spectrum of genetically determined melanocytic proliferations that develop due to endogenous pathways, in contrast to "true" acquired melanocytic nevi, dermatoscopically showing reticular pattern, that develop due to exogeneous factors such as UV-exposure.
Detailed Description
The investigations to this study will verify whether small CMN, "early" AMN and dermal nevi, characterized by globular pattern differ in their genetic alterations compared to reticular typed nevi. It will be expected that globular typed nevi and eventually dermal nevi lack B-RAF mutations whereas reticular nevi show alterations in the B-RAF gene. Study location: Graz
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nevi
Keywords
Dermoscopy, Histopathology, Genetics, Nevi, Nevogenesis
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
43 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Nevi from participants
Arm Type
Experimental
Arm Description
Benign nevi dermoscopically sub-classified into 4 dermoscopic types (i.e., with globular, reticular, mixed pattern with globules in the center and mixed pattern with globules at the periphery) were excised from healthy volunteers for further genetical analysis
Intervention Type
Genetic
Intervention Name(s)
To test the frequency of BRAF and NRAS mutations among nevi
Other Intervention Name(s)
NM_004333; Homo sapiens v-raf murine sarcoma viral oncogene homolog B1
Intervention Description
Benign nevi excised for the study purpose where genetically analyzed for the presence/absence of BRAF and NRAS mutations
Primary Outcome Measure Information:
Title
Frequency of BRAF Mutations Among Nevi
Description
All nevi were analyzed for BRAF mutations using the (less sensitive) Sanger method. A random subset of nevi was also analyzed using the (more sensitive) Ultradeep pyro-sequencing method (UDPS). The frequency is reported here as the number of BRAF mutations found by each method.
Time Frame
up to 30 months
Secondary Outcome Measure Information:
Title
Frequency of NRAS Mutations Among Nevi
Description
All nevi were analyzed for NRAS mutations using the (less sensitive) Sanger method. The (more sensitive) Ultradeep pyro-sequencing method (UDPS) is not applicable for this mutation. The frequency is reported here as the number of NRAS mutations from the analyzed nevi.
Time Frame
30 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
9 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy individuals aged 9 to 80 years showing one or more dermoscopically benign nevi with either uniform globular-cobblestone pattern or reticular pattern or a combination of both types
Exclusion Criteria:
Children under the age of 9 years
Pregnant woman
Patients with atypical nevi (i.e., melanoma cannot be clinically ruled out)
Patients with immunosuppression
Patients with sun exposure 4 weeks before enrollment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Iris Zalaudek, MD
Organizational Affiliation
Department of Dermatology, Medical University of Graz
Official's Role
Study Chair
Facility Information:
Facility Name
Department of Dermatology, Medical University of Graz
City
Graz
ZIP/Postal Code
8036
Country
Austria
12. IPD Sharing Statement
Citations:
PubMed Identifier
16433800
Citation
Zalaudek I, Grinschgl S, Argenziano G, Marghoob AA, Blum A, Richtig E, Wolf IH, Fink-Puches R, Kerl H, Soyer HP, Hofmann-Wellenhof R. Age-related prevalence of dermoscopy patterns in acquired melanocytic naevi. Br J Dermatol. 2006 Feb;154(2):299-304. doi: 10.1111/j.1365-2133.2005.06973.x.
Results Reference
background
PubMed Identifier
16536840
Citation
Zalaudek I, Hofmann-Wellenhof R, Soyer HP, Ferrara G, Argenziano G. Naevogenesis: new thoughts based on dermoscopy. Br J Dermatol. 2006 Apr;154(4):793-4. doi: 10.1111/j.1365-2133.2006.07152.x. No abstract available.
Results Reference
background
PubMed Identifier
19833408
Citation
Pellacani G, Scope A, Ferrari B, Pupelli G, Bassoli S, Longo C, Cesinaro AM, Argenziano G, Hofmann-Wellenhof R, Malvehy J, Marghoob AA, Puig S, Seidenari S, Soyer HP, Zalaudek I. New insights into nevogenesis: in vivo characterization and follow-up of melanocytic nevi by reflectance confocal microscopy. J Am Acad Dermatol. 2009 Dec;61(6):1001-13. doi: 10.1016/j.jaad.2009.04.018. Epub 2009 Oct 14.
Results Reference
derived
Links:
URL
http://www.fwf.ac.at/
Description
Webpage of the sponsoring organization
Learn more about this trial
Study to Test Genetic Alterations Among Different Dermoscopic Types of Melanocytic Nevi.
We'll reach out to this number within 24 hrs